Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
JFL Life Sciences
|
Sandu Pharmaceutical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.51 % | 11.5 % | 3.94 % |
|
5yr average Equity Multiplier
|
3.24 | 3.23 | 1.34 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 0.95 | 1.27 |
|
5yr Avg Net Profit Margin
|
1.44 % | 4.98 % | 2.31 % |
|
Price to Book
|
0.7 | 1.14 | 1.09 |
|
P/E
|
0.0 | 10.71 | 29.39 |
|
5yr Avg Cash Conversion Cycle
|
57.8 Days | 217.93 Days | 27.73 Days |
|
Inventory Days
|
76.41 Days | 85.64 Days | 71.51 Days |
|
Days Receivable
|
195.39 Days | 186.74 Days | 26.2 Days |
|
Days Payable
|
179.71 Days | 98.82 Days | 79.23 Days |
|
5yr Average Interest Coverage Ratio
|
2.65 | 3.02 | 28.27 |
|
5yr Avg ROCE
|
22.81 % | 18.94 % | 5.77 % |
|
5yr Avg Operating Profit Margin
|
10.92 % | 9.53 % | 3.87 % |
|
5 yr average Debt to Equity
|
0.87 | 1.19 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | 55.85 % | -1.69 % |
|
5yr Average Return on Assets
|
3.23 % | 4.15 % | 2.94 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 67.47 % | 42.9 % |
|
Share Pledged by Promoters
|
44.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.55 % | 0.0 | -7.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
JFL Life Sciences
|
Sandu Pharmaceutical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|